See All Slides - tctmd.com

Slides

$Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up$

Presentation Cell Therapy 2013

Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up

Presenter: Anders Bruun Mathiasen

January 23, 2013

Presentation Cell Therapy 2013

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Presenter: Wolfgang-Michael Franz

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Presenter: Frank J. Giordano

January 22, 2013

Presentation Cell Therapy 2013

IK 5001 - A Novel Approach to Myocardial Remodeling

Presenter: David F. Kong

January 22, 2013

Presentation Cell Therapy 2013

Swiss AMI Study: Long-term Findings

Presenter: Daniel S?rder

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

Presentation

Same-Day Discharge Compared with Overnight Hospitalization After Uncomplicated PCI

Presenter: E. Abdelaal

January 22, 2013

Presentation Cell Therapy 2013

Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR

Presenter: Eduardo Marb?n

January 22, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Advertisement

Slides

Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

IK 5001 - A Novel Approach to Myocardial Remodeling

Swiss AMI Study: Long-term Findings

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Same-Day Discharge Compared with Overnight Hospitalization After Uncomplicated PCI

Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR

EXCELLENT Trial Design

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content